06/03/2026
What is your next problem to solve? Students come up with amazing projects!
A pharmaceutical commercial came on TV.
You've seen a thousand of them. The cheerful music. The smiling actors. And then the rapid-fire voice at the end rattling off side effects — nausea, dizziness, in rare cases, death.
Most people reach for the remote.
Sofia Tomov, age 12, reached for a notebook.
She had one question she couldn't shake loose: Why do medicines save some people — and kill others?
That question, born in a living room in Knoxville, Tennessee, would send her down a path that very few adults — let alone children — had ever walked.
She started researching. And what she found shook her to the core.
Adverse drug reactions — where medications prescribed to heal a person instead cause serious harm — are one of the leading causes of death in the United States. Not rare. Not fringe. More deadly each year than AIDS, diabetes, pulmonary disease, and pneumonia combined, according to FDA data. Thousands of people, every single year, going to a doctor for help and never coming home.
A hidden crisis. Quietly devastating. Largely preventable.
Sofia kept pulling the thread.
She discovered that the root of the problem isn't negligence or bad doctors. It's genetics. Every human being carries a unique DNA blueprint, and certain gene variants make some people dangerously vulnerable to specific medications. A drug that saves one life can end another — not because of a dosage error, not because of a mistake — but because of invisible differences written into a person's DNA at birth.
The tragedy? The science to detect these differences already exists.
Doctors can sequence a person's genome and identify which medications might be dangerous for them. The problem is time. In an emergency — a heart attack, a seizure, a stroke — a patient doesn't have the hours it traditionally takes to analyze billions of DNA base pairs. They have minutes. Sometimes seconds.
The information existed. The tools existed. The gap was speed.
Sofia, a 12-year-old home-schooled student with a love of fencing, electric guitar, and nature journaling, decided that wasn't good enough.
She dug into the existing genomic search algorithms — the code that doctors and researchers were already using — and figured out why they were so slow. Then she modified and optimized the algorithm to run across multiple computer processors simultaneously, dramatically cutting down the time needed to scan a genome for dangerous mutations.
What had once taken hours could now happen in a fraction of that time. Fast enough, potentially, to matter in an emergency room. Fast enough to give a doctor the information they needed before choosing a medication that could kill their patient.
Let that settle for a moment.
A 12-year-old girl, with no research laboratory, no PhD, no funding, and no team — did that.
She didn't discover the problem existed. Researchers had known about adverse drug reactions for decades. They knew the genetic component. They knew the algorithms were too slow. The problem had been sitting there, acknowledged, unsolved.
It took a child watching a TV commercial to say: What if we just fixed it?
In 2016, Sofia entered the Discovery Education 3M Young Scientist Challenge, one of the most respected science competitions for middle school students in the country. Out of thousands of entries, she was selected as one of ten national finalists. She spent the summer working with her assigned mentor, 3M scientist John Henderson, refining her project before presenting it at 3M's headquarters in St. Paul, Minnesota.
This wasn't her first time turning curiosity into something real. She had already filed a patent for a medication safety invention and published a children's book. And in the fall of 2016, she became a visiting student at the University of Tennessee-Knoxville — taking a college computer science course while most of her peers were navigating middle school hallways.
But none of that is the point of this story.
The point is this: Sofia did not wait until she was old enough. She did not wait for a teacher to assign the problem. She did not decide that life-and-death medical research was someone else's territory.
She watched a commercial. She felt curious. She followed that curiosity without stopping — all the way to an algorithm that could one day save lives.
There is something quietly devastating about the question her story asks of the rest of us.
How many of us have had a moment like hers? A flicker of "why does that happen?" or "isn't there a better way?" And how quickly did we let that question evaporate — because we were busy, because we assumed someone smarter was already on it, because we decided the problem was too big for us?
Sofia Tomov didn't do that.
She was 12 years old and she decided the problem was hers to work on. Not to fully solve overnight — she was honest that her project was a proof of concept, that more work lay ahead. But to move forward. To try. To contribute something real.
Her project is still a step on a longer road. But it's a step that didn't exist before she took it.
And somewhere down that road, there is a patient in an emergency room who will be given the right medication instead of the wrong one — quickly enough to survive — because a 12-year-old in Tennessee couldn't stop thinking about a question most people would have forgotten by morning.
That's not a small thing.
That's everything.
The next time you feel a question tugging at you — the kind that makes you think "someone should really fix that" — remember Sofia Tomov. Maybe that someone is you.
05/30/2026
05/20/2026
05/20/2026
05/20/2026
04/23/2026
04/14/2026
03/29/2026
02/08/2026